Insiders · NGNE

NGNE insider transactions

Neurogene Inc. (NGNE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for NGNE

• 5d
  SEC Form 3 filed by new insider Shafer Christina

  3 - Neurogene Inc. (0001404644) (Issuer)
• 27d
  SEC Form 4 filed by Cvijic Christine Mikail

  4 - Neurogene Inc. (0001404644) (Issuer)
• 27d
  SEC Form 4 filed by Jordan Julie

  4 - Neurogene Inc. (0001404644) (Issuer)
• 27d
  SEC Form 4 filed by Mcminn Rachel

  4 - Neurogene Inc. (0001404644) (Issuer)
• 40d
  Chief Scientific Officer Cobb Stuart sold $141,446 worth of shares (6,797 units at $20.81), decreasing direct ownership by 18% to 30,497 units (SEC Form 4)

  4 - Neurogene Inc. (0001404644) (Issuer)
• 40d
  President and CFO Cvijic Christine Mikail sold $84,176 worth of shares (4,045 units at $20.81) (SEC Form 4)

  4 - Neurogene Inc. (0001404644) (Issuer)
• 54d
  President and CFO Cvijic Christine Mikail sold $120,526 worth of shares (4,800 units at $25.11) (SEC Form 4)

  4 - Neurogene Inc. (0001404644) (Issuer)
• 60d
  Chief Scientific Officer Cobb Stuart was granted 16,500 shares, increasing direct ownership by 79% to 37,294 units (SEC Form 4)

  4 - Neurogene Inc. (0001404644) (Issuer)
• 60d
  Chief Medical Officer Jordan Julie was granted 4,900 shares, increasing direct ownership by 58% to 13,300 units (SEC Form 4)

  4 - Neurogene Inc. (0001404644) (Issuer)
• 60d
  President and CFO Cvijic Christine Mikail was granted 22,000 shares, increasing direct ownership by 24% to 114,643 units (SEC Form 4)

  4 - Neurogene Inc. (0001404644) (Issuer)
• 60d
  Chief Executive Officer Mcminn Rachel was granted 25,900 shares, increasing direct ownership by 2% to 1,347,659 units (SEC Form 4)

  4 - Neurogene Inc. (0001404644) (Issuer)
• 60d
  SEC Form 4 filed by Director Palekar Rohan

  4 - Neurogene Inc. (0001404644) (Issuer)
• 60d
  SEC Form 4 filed by Director Baffi Robert

  4 - Neurogene Inc. (0001404644) (Issuer)
• 60d
  SEC Form 4 filed by Director Noonberg Sarah B.

  4 - Neurogene Inc. (0001404644) (Issuer)
• 60d
  SEC Form 4 filed by Director Freedland Cory S.

  4 - Neurogene Inc. (0001404644) (Issuer)
• 60d
  SEC Form 4 filed by Director Woods Keith

  4 - Neurogene Inc. (0001404644) (Issuer)
• 317d
  SEC Form 4 filed by Director Baffi Robert

  4 - Neurogene Inc. (0001404644) (Issuer)
• 317d
  SEC Form 4 filed by Director Woods Robert Keith

  4 - Neurogene Inc. (0001404644) (Issuer)
• 317d
  SEC Form 4 filed by Director Palekar Rohan

  4 - Neurogene Inc. (0001404644) (Issuer)
• 317d
  SEC Form 4 filed by Director Freedland Cory S.

  4 - Neurogene Inc. (0001404644) (Issuer)
• 317d
  SEC Form 4 filed by Director Noonberg Sarah B.

  4 - Neurogene Inc. (0001404644) (Issuer)
• 346d
  Chief Scientific Officer Cobb Stuart sold $103,003 worth of shares (6,797 units at $15.15), decreasing direct ownership by 25% to 20,794 units (SEC Form 4)

  4 - Neurogene Inc. (0001404644) (Issuer)
• 393d
  Chief Scientific Officer Cobb Stuart was granted 7,200 shares, increasing direct ownership by 35% to 27,591 units (SEC Form 4)

  4 - Neurogene Inc. (0001404644) (Issuer)
• 393d
  President and CFO Cvijic Christine Mikail was granted 20,300 shares (SEC Form 4)

  4 - Neurogene Inc. (0001404644) (Issuer)
• 393d
  Chief Medical Officer Jordan Julie was granted 8,400 shares (SEC Form 4)

  4 - Neurogene Inc. (0001404644) (Issuer)
• 393d
  Chief Executive Officer Mcminn Rachel was granted 23,900 shares, increasing direct ownership by 2% to 1,274,259 units (SEC Form 4)

  4 - Neurogene Inc. (0001404644) (Issuer)
• 405d
  President and CFO Cvijic Christine Mikail sold $76,247 worth of shares (4,501 units at $16.94) (SEC Form 4)

  4 - Neurogene Inc. (0001404644) (Issuer)
• 515d
  Large owner Samsara Biocapital Gp, Llc bought $1,259,623 worth of shares (48,770 units at $25.83) (SEC Form 4)

  4 - Neurogene Inc. (0001404644) (Issuer)
• 515d
  New insider Samsara Biocapital Gp, Llc claimed ownership of 1,668,357 shares (SEC Form 3)

  3 - Neurogene Inc. (0001404644) (Issuer)
• 516d
  President and CFO Cvijic Christine Mikail bought $491,400 worth of shares (24,000 units at $20.48), increasing direct ownership by 45% to 76,844 units (SEC Form 4)

  4 - Neurogene Inc. (0001404644) (Issuer)
• 516d
  Chief Executive Officer Mcminn Rachel bought $969,000 worth of shares (47,500 units at $20.40), increasing direct ownership by 4% to 1,297,859 units (SEC Form 4)

  4 - Neurogene Inc. (0001404644) (Issuer)
• 678d
  SEC Form 4 filed by Director Woods Robert Keith

  4 - Neurogene Inc. (0001404644) (Issuer)
• 678d
  SEC Form 4 filed by Director Palekar Rohan

  4 - Neurogene Inc. (0001404644) (Issuer)
• 678d
  SEC Form 4 filed by Director Baffi Robert

  4 - Neurogene Inc. (0001404644) (Issuer)
• 678d
  SEC Form 4 filed by Director Noonberg Sarah B.

  4 - Neurogene Inc. (0001404644) (Issuer)
• 678d
  SEC Form 4 filed by Director Freedland Cory S.

  4 - Neurogene Inc. (0001404644) (Issuer)
• 772d
  SEC Form 4 filed by Mcminn Rachel

  4 - Neurogene Inc. (0001404644) (Issuer)
• 772d
  Cvijic Christine Mikail was granted 31,903 shares, increasing direct ownership by 152% to 52,844 units (SEC Form 4)

  4 - Neurogene Inc. (0001404644) (Issuer)
• 772d
  Cobb Stuart was granted 20,391 shares (SEC Form 4)

  4 - Neurogene Inc. (0001404644) (Issuer)